Microencapsulation Market Worth 10.76 Billion USD by 2022

The microencapsulation market, in terms of value, is projected to reach USD 10.76 Billion by 2022 from USD 5.71 Billion in 2016, at a CAGR of 11.4% from 2017 to 2022.


Seattle, WA -- (SBWIRE) -- 09/04/2017 -- The report "Microencapsulation Market by Technology (Spray, Emulsion, Dripping), Core Material (Pharmaceutical & Healthcare Drugs, Food Additives), Application (Pharmaceuticals, Food & Beverages), Shell material, and Region - Global Forecast to 2022", The microencapsulation market, in terms of value, is projected to reach USD 10.76 Billion by 2022 from USD 5.71 Billion in 2016, at a CAGR of 11.4% from 2017 to 2022.

Browse 83 Market Data Tables and 37 Figures spread through 176 Pages and in-depth TOC on "Microencapsulation Market - Global Forecast to 2022"

Download PDF Brochure

Early buyers will receive 10% customization on this report.

The market is driven by factors such as the rise in demand for agrochemical applications, increased applications in the food industry to fortify products, growing market for controlled and targeted drug delivery in the pharmaceuticals industry, and growing demand for enhancing product functionality in various industries.

Make an Inquiry

"Pharmaceutical & healthcare products segment dominated the market in 2016"

Microencapsulation is widely used in the healthcare and pharmaceutical sectors for controlled drug delivery. Microencapsulated products are largely used for the replacement of therapeutic agents and in vaccines. The demand for microencapsulation is increasing globally due to its wide applications in pharmaceutical & healthcare products.

"Spray technologies segment dominated the market, by technology, in 2016"

Spray technologies include spray drying, spray chilling, centrifugal extrusion, and spinning disk/rotational suspension separation. Spray drying is a widely used method for converting a liquid particle into a dry powder by atomization into a stream of hot gas. The spray technologies segment dominated the market due to its cost-effectiveness.

"Carbohydrates segment is projected to grow at the highest CAGR, by shell material, from 2017 to 2022"

Carbohydrates are the most preferred choice of shell material in food ingredient encapsulation since it is a biomaterial. The molecules of complex carbohydrates, which are also called polysaccharides (such as hydrocolloids, starch, cellulose, or glycogen), consist of a number of sugar molecules bonded together. Properties of polysaccharides such as biocompatibility, solubility, the potential for modification, and innate bioactivity provide significant potential for their use in drug delivery systems.

"Pharmaceutical & healthcare drugs segment dominated the market, by core material, in 2016"

Microencapsulation of drug ingredients in shell particles is required for taste or color masking, enhancing bioavailability, reducing side effects, and greater tissue penetration of drugs. Microencapsulation technology is a cost-effective option for increasing the bioavailability of drugs when compared to other technologies, which is a significant driver for the market growth.

"Asia Pacific is projected to be the fastest-growing market for microencapsulation during the forecast period"

The need for microencapsulation has increased in the Asia Pacific region in recent years, owing to the increased demand for functional products in various industries, particularly in the food & beverages industry. The growth in this market is fueled by the economic development in countries such as China, Japan, and India. China is projected to dominate the Asia Pacific microencapsulation market due to the increasing technological advancements in various sectors and increasing R&D expenditure.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It includes the profiles of leading companies such as BASF SE (Germany), Syngenta Crop Protection AG (Switzerland), Royal FrieslandCampina N.V. (Netherlands), Koninklijke DSM N.V. (Netherlands), and Givaudan SA (Switzerland).

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Rohan
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States